Biodegradable Implants Market is set for steady growth to US$ 10.31 billion by 2031, led by North America 39% of global market share| Key Players:- Evonik, Johnson & Johnson, Medtronic.

The Global Biodegradable Implants Market reached US$ 5.24 billion in 2023 and is expected to reach US$ 10.31 billion by 2031, growing at a CAGR of 8.9% during the forecast period 2024-2031.

Market growth is driven by the rising prevalence of orthopedic disorders and trauma cases, increasing demand for minimally invasive surgeries, and the growing need to eliminate secondary implant removal procedures. Additionally, advancements in biodegradable polymers and bioresorbable metals, expanding use of implants in orthopedic, cardiovascular, and dental applications, and improving clinical outcomes and regulatory approvals are further supporting market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/biodegradable-implants-market?pratik

United States: Key Industry Developments
✅ December 2025: Bioretec expanded its RemeOsTM bioresorbable implant portfolio with FDA-cleared orthopedic screws featuring enhanced magnesium alloy compositions, reducing resorption time by 25% for faster bone healing in trauma cases.
​
✅ September 2025: The U.S. bio-resorbable implants market saw strong growth driven by R&D investments from Medtronic and Johnson & Johnson, with orthopedic applications leading due to minimally invasive procedure adoption.
​
✅ August 2025: Global Insight Services reported accelerated market expansion for biodegradable implant devices, highlighting U.S. leadership in cardiovascular stents amid rising demand from aging populations.
​
Asia Pacific / Japan: Key Industry Developments
✅ November 2025: Japan's biodegradable implants sector advanced with new clinical trials for polylactic acid-based scaffolds, supported by government subsidies for regenerative medicine in orthopedic reconstruction.
​
✅ September 2025: Coherent Market Insights noted robust adoption of bioresorbable technologies in Japan, fueled by collaborations between local firms and global players like Stryker for cardiovascular applications.
​
✅ August 2025: Japanese regulators fast-tracked approvals for hybrid biodegradable implants combining polymers and alloys, targeting reduced secondary surgeries in high-volume orthopedic procedures.

Recent M&A Activity:-
Teleflex - Biotronik Vascular Intervention (July 14, 2025)
Teleflex finalized its acquisition of substantially all of Biotronik's vascular intervention business for $895 million, enhancing its portfolio in coronary and peripheral interventions with drug-coated balloons, covered stents, and drug-eluting stents. This deal supports expansion of clinical trials for Freesolve, a sirolimus-eluting resorbable metallic scaffold technology aligned with biodegradable implant innovations.
​
Merit Medical - Biolife Delaware (May 20, 2025)
Merit Medical acquired Biolife Delaware for approximately $120 million in a merger transaction, adding StatSeal and WoundSeal hemostatic discs to bolster interventional products for oncology, vascular access, and spine surgery. The acquisition strengthens Merit's hemostatic solutions amid growing demand for procedure-efficient devices complementary to implant markets.
​
Tyber Medical, Intech & Resolve Surgical Technologies (April 23, 2025)
Tyber Medical, Intech, and Resolve Surgical Technologies merged to form a next-generation medtech CDMO+ platform, unifying implant innovation, precision manufacturing, and regulatory expertise with over 100 510(k)-cleared implant systems. Backed by investors like Montagu, the combined entity accelerates OEM time-to-market for orthopedic and trauma implants.

Market Segmentation Analysis:
By Product Type: Stents vs Scaffolds vs Others
Stents dominate with approximately 37% market share in 2024, driven by cardiovascular applications requiring temporary vessel support.
Scaffolds and orthopedic screws/pins follow at 26%, favored for bone regeneration without removal surgeries, while others like drug-delivery implants hold the rest amid rising regenerative medicine demand.
​
By Material: Polymers vs Ceramics vs Metals
Polymers (e.g., PLGA, PCL) lead with over 50% share in 2025, due to tunable degradation rates suiting diverse implants.
​Ceramics and bioresorbable metals (e.g., magnesium alloys) account for 22.3% each, gaining traction in load-bearing orthopedic uses for strength and biocompatibility.
​
By Application: Orthopedic vs Cardiovascular vs Others
Orthopedic applications command 45% share in 2024, propelled by aging populations and fracture fixation needs.
​Cardiovascular follows at 30%, focused on stents for artery repair, with dental and tissue engineering others at 25% amid minimally invasive trends.
​
By End-User: Hospitals vs Clinics vs Others
Hospitals hold the largest share at around 54% in 2025, as primary sites for complex implant procedures.​
Ambulatory surgical centers and specialty clinics capture 24%, boosted by outpatient shifts, while home care and others grow with telehealth integration.

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=biodegradable-implants-market?pratik

Growth Drivers:-
Rising prevalence of orthopedic, cardiovascular, and dental disorders driving demand for temporary implants
Growing preference for minimally invasive and resorbable medical solutions reducing repeat surgeries
Increasing aging population globally boosting implant-based treatment volumes
Technological advancements in bioresorbable polymers and magnesium-based materials
Higher adoption of biodegradable implants in trauma and sports injury treatments
Favorable regulatory support and faster approvals for bioresorbable medical devices
Increasing healthcare expenditure and expansion of advanced surgical infrastructure

Regional Insights:
North America commands the largest share of the Biodegradable Implants Market, estimated at around 39% in recent assessments, driven by advanced healthcare infrastructure, high prevalence of orthopedic and cardiovascular conditions, substantial R&D investments, and favorable reimbursement policies in the US.
​
Europe follows as the second-largest region, with approximately 28% market share, benefiting from stringent medical device regulations, rising adoption in countries like Germany, France, and the UK, and strong focus on bioabsorbable technologies for minimally invasive procedures amid steady market maturation.
​
Asia Pacific ranks third in market share at about 21%, yet exhibits the fastest growth potential with elevated CAGRs in nations such as China, India, and Japan, fueled by expanding healthcare access, government support for medical innovation, aging demographics, and localized manufacturing investments.

Speak to Our Analyst and Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/biodegradable-implants-market?pratik

Key Players:
The major global players in the biodegradable implants market include Evonik, Johnson & Johnson, Medtronic, Stryker, Smith+Nephew, Boston Scientific Corporation, Inion, Bioretec, Arthrex, Inc, Syntellix among others.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?pratik

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele

This release was published on openPR.